1. Extending the Scope of Mitral Valve Repair in Rheumatic Disease
Bachar El Oumeiri, MD, Munir Boodhwani, MD, MMSc, David Glineur, MD, Laurent De Kerchove, MD, Alain Poncelet, MD, Parla Astarci, MD, Agnes Pasquet, MD, Jean-Louis Vanoverschelde, MD, PhD, Robert Verhelst, MD, Jean Rubay, MD, PhD, Philipe Noirhomme, MD, Gébrine El Khoury, MD 
The Annals of Thoracic Surgery 
Volume 87, Issue 6, Pages (June 2009)
DOI: /j.athoracsur
Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
(A) Rheumatic mitral valve with classic “fish mouth” appearance. (B) The dotted line indicates the area to be resected. (C) Appearance after resection of leaflet edge and supporting chordae and reconstruction with polytetrafluoroethylene neochordae.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
(A) Harvested posterior leaflet of tricuspid valve with its chordae and papillary muscle. (B) Reconstruction of anterior commissure with tricuspid autograft tissue.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Clinical and echocardiographic outcome in patients undergoing rheumatic mitral valve repair. (A) Overall survival (dashed line) and freedom from cardiac death (solid line) were 81% ± 7% and 98% ± 2%, respectively, at 10 years. (B) Freedom from mitral valve reoperation (due to severe recurrent mitral stenosis) was 94% ± 5% at 10 years. (C) Freedom from recurrent mitral regurgitation (>2+) was 83% ± 9% at 8 years.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions